Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
08/15/16 10-Q Quarterly report pursuant to Section 13 or 15(d) 27
08/09/16 8-K Current report filing
Documents
5
08/08/16 3 Initial statement of beneficial ownership of securities 2
08/08/16 3 Initial statement of beneficial ownership of securities 2
08/02/16 8-K Current report filing
Documents
5
07/22/16 8-K Current report filing
Documents
5
07/21/16 S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Documents
22
06/17/16 8-K Current report filing
Documents
9
06/16/16 10-Q Quarterly report pursuant to Section 13 or 15(d) 23
06/07/16 3 Initial statement of beneficial ownership of securities 2
RSS